I partially agree. Selling the shares to Aspire to generate the extra funds needed now to get the new trials up and running in certainly Leo's doing. But this should not have been occurring at the sub-$2 range. CTIX should be up in the $4-5+ range where it belongs for the value of the pipeline. It is because of the concerted effort to attack and hurt CTIX's value among retail shareholders that we are here. Leo just doesn't have much choice at this point because the funds are needed.